Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing study of Aricept in dementia with Lewy bodies
jRCT1080222744Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in dementia with Lewy bodies (DLB) comparing Aricept with Placebo (2 arms). Primary endpoint: CIBIC-plus global clinical status. Started Feb 2015; status: completed.
02
Drugs
donepezil
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on jRCT1080222744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222744.